RIO DE JANEIRO – A massive fire raced through Brazil’s 200-year-old National Museum in Rio de Janeiro on Sunday, probably destroying its collection of more than 20 million items, ranging from archeological finds to historical memorabilia.
Equity Analysis and News Dow Jones Industrial Average: Trend Remains Moderately Bullish DAX: Bearish Sequence Brings July Lows in Focus Dow Jones Industrial Average: Trend Remains Moderately Bullish Another week of gains for the Dow Jones with the index now hovering around the 26,000 level. Eyes are on for a weekly close above 26,000, which will likely confirm that the uptrend in the index is still intact. Alongside this, the Dow Jones is still playing catch up relative to its US counterparts, which have hit record highs.
Ford Motor Co. is unlikely to be the last to say forget it to a vehicle that doesn’t make financial sense for the U.S. market anymore thanks to Donald Trump’s trade wars.
The market may begin looking different after Labor Day.
US consumers are hungry for credit card rewards. Seventy-five percent now have a rewards program attached to their most preferred card, up from 58% two years ago. And with consumer debt practically hitting pre-recession levels, it doesn’t look like anyone’s planning to slow their spending.
A year ago, Jeff Lunnen could have shown a prospective oilfield service company 15 to 20 industrial properties for their consideration.
McDonald’s is taking short term pain for long term gain when remodeling its fast-food experience, says a team of analysts from Jefferies.
One of the richest veins of manganese in North America is in the city of Emily’s backyard.
On Saturday, bitcoin’s (BTC) price swung upwards starting the day around $7,042 but after a couple of jumps reached around $7,218 at 20:15 before falling back to close at $7,192. Still this was a reasonable gain after the price recently fell below $7,000.
New bowel cancer target could help chill disease aggression and spread
FDA emphasizes available information in final CAR-T guidance while acknowledging lack of precedent
Clarius tacks on European nod for whole-body hand-held ultrasound scanner
Elicio’s therapeutic cancer vaccine boosts T-cell therapy response in mice while biotech awaits phase 2 data
Sarepta’s next DMD drug seems to get the job done, but Elevidys casts long shadow
After GSK and Novartis handoffs, Laekna’s drug fails ovarian cancer trial
Ascendis spins out new ophthalmology biotech Eyconis, gaining equity and biobucks
Next-gen prostate cancer test maker Cleveland Diagnostics rocks to $75M fundraising
Philips agrees to FDA consent decree halting US sales of CPAP respiratory care devices
Samsung taps Lunit to bring AI detection to its chest X-ray scanners
